Miller Wendy A, Gordon Adam J, Clothier Barbara A, Ackland Princess E, Bounthavong Mark, Garcia Carla, Kenny Marie E, Noorbaloochi Siamak, Hagedorn Hildi J
Center for Care Delivery and Outcomes Research, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Implement Res Pract. 2023 Sep 14;4:26334895231199463. doi: 10.1177/26334895231199463. eCollection 2023 Jan-Dec.
Barriers at the system, clinician, and patient level limit access to medications for opioid use disorder (MOUD). The Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD) study implemented an external facilitation strategy within the Veterans Health Administration (VHA) aimed at facility-level barriers to improve uptake of MOUD. During ADaPT-OUD, an independent Academic Detailing Services Opioid Agonist Treatment of OUD Campaign was co-occurring and aimed to increase evidence-based practice for OUD at the clinician level. While both these initiatives aim to increase MOUD reach, they address different barriers and did not intentionally collaborate. Thus, understanding the interaction between these two independent implementation initiatives and their effect on MOUD reach will further inform and mold future implementation efforts of MOUD.
This was a secondary analysis of the ADaPT-OUD study that included 35 VHA facilities in the lowest quartile of MOUD reach; eight received the ADaPT-OUD external facilitation and 27 matched sites received implementation as usual. The number of academic detailing (AD) visits during ADaPT-OUD was used as a proxy for the intensity of Academic Detailing for OUD Campaign activity. The interaction between external facilitation status and AD intensity was evaluated by comparing the change in facility-level MOUD reach.
There was a general increase in the number of AD visits, in both external facilitation and implementation as usual sites, over the course of ADaPT-OUD's implementation period. A non-statistically significant, positively sloped, linear relationship was observed between average number of AD visits per quarter and change in MOUD reach in facilities also receiving ADaPT-OUD external facilitation that was not observed in the implementation as usual sites.
Co-occurring initiatives focusing on different barriers to MOUD access have the potential to further increase MOUD in low-performing facilities, but further research into timing, quality, and collaboration between initiatives are warranted.
系统、临床医生和患者层面的障碍限制了阿片类物质使用障碍(MOUD)药物的可及性。推进阿片类物质使用障碍药物治疗(ADaPT - OUD)研究在退伍军人健康管理局(VHA)内实施了一项外部促进策略,旨在解决机构层面的障碍,以提高MOUD的使用率。在ADaPT - OUD研究期间,一项独立的学术推广服务阿片类物质使用障碍激动剂治疗活动同时开展,旨在提高临床医生层面针对阿片类物质使用障碍的循证实践。虽然这两项举措都旨在扩大MOUD的覆盖范围,但它们解决的是不同的障碍,且并未有意开展合作。因此,了解这两项独立实施举措之间的相互作用及其对MOUD覆盖范围的影响,将为MOUD未来的实施工作提供进一步的信息并塑造其方向。
这是对ADaPT - OUD研究的二次分析,该研究纳入了MOUD覆盖范围处于最低四分位数的35个VHA机构;其中8个机构接受了ADaPT - OUD外部促进,27个匹配机构按常规方式实施。ADaPT - OUD期间学术推广(AD)访问的次数被用作阿片类物质使用障碍治疗活动学术推广强度的指标。通过比较机构层面MOUD覆盖范围的变化,评估外部促进状态与AD强度之间的相互作用。
在ADaPT - OUD的实施期间,外部促进机构和常规实施机构的AD访问次数总体上都有所增加。在接受ADaPT - OUD外部促进的机构中,观察到每季度平均AD访问次数与MOUD覆盖范围变化之间存在非统计学显著的、正斜率的线性关系,而在常规实施机构中未观察到这种关系。
针对MOUD获取的不同障碍同时开展的举措,有可能进一步提高表现不佳机构的MOUD使用率,但有必要对举措之间的时间安排、质量和合作进行进一步研究。